|1|Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm. (24417737)
Aso A.... Takayanagi R.
|2|Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma. (23754313)
Unruh D.... Bogdanov V.Y.
|3|Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. (23755913)
Cheng M.F.... Jin J.S.
|4|MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. (23991015)
Kadera B.E.... Donahue T.R.
|5|RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients. (24167655)
Muniz V.P.... Quelle D.E.
|6|Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma. (23718921)
Mardin W.A.... Mees S.T.
|7|Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. (24111684)
Chatterjee D.... Wang H.
|8|IL-1I+ expression in pancreatic ductal adenocarcinoma affects the tumor cell migration and is regulated by the p38MAPK signaling pathway. (23951028)
Tjomsland V.... Larsson M.
|9|Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma. (23445338)
Tinchon C.... Bauernhofer T.
|10|High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma. (24088390)
Stenzinger A.... Weichert W.
|11|Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutional phase 2 trial. (23838925)
Motoi F.... Unno M.
|12|Prognostic significance of PUMA in pancreatic ductal adenocarcinoma. (23321162)
Du Q.H.... Xu Y.B.
|13|Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma. (22086503)
Valsecchi M.E.... Witkiewicz A.K.
|14|The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. (22699621)
PAcrez-Mancera P.A.... Tuveson D.A.
|15|Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. (22525021)
Park J.B.... Han D.J.
|16|Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma. (23162631)
Jiang C.Y.... Wang L.B.
|17|Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. (22323115)
Rybarczyk P.... Ouadid-Ahidouch H.
|18|Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays. (22395988)
Park J.K.... Kim Y.T.
|19|Loss of heterozygosity status of D9S105 marker is associated with downregulation of KrA1ppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions. (21412023)
Funel N.... Campani D.
|20|Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma. (21404460)
Grochola L.F.... WA1rl P.
|21|Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. (21444679)
Jamieson N.B.... Oien K.A.
|22|Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. (21283040)
Coppola D.... Wang H.G.
|23|Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literature. (21809164)
Rittenhouse D.W.... Yeo C.J.
|24|Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. (21088996)
Bhatti I.... Larvin M.
|25|Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma. (21484522)
Walters D.M.... Bauer T.W.
|26|Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma. (21615621)
Chung H.W.... Lim J.B.
|27|Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis. (21713779)
La Torre M.... Ziparo V.
|28|Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma. (21129814)
RAPder C.... Kalthoff H.
|29|Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. (20863812)
Wang W.... Kleeff J.
|30|Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. (20162456)
Ben Q.W.... Yuan Y.Z.
|31|High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (20732965)
Liang J.J.... Wang H.
|32|Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. (20811670)
Bergmann F.... Sebens MA1erkAPster S.
|33|Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression. (19212105)
Zhou L.... Yuan Y.
|34|Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma. (19649555)
Sergeant G.... Topal B.
|35|MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues. (19077456)
Seux M.... Dusetti N.J.
|36|Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma. (19672209)
Welsch T.... Schmidt J.
|37|Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma. (19077459)
Cui Y.... Han J.
|38|Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. (18787902)
Smith R.A.... Ghaneh P.
|39|Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. (18708761)
Reiser-Erkan C.... Kleeff J.
|40|Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case. (17897923)
Krishnasamy R.... Agarwal A.K.
|41|Neurotensin is a versatile modulator of in vitro human pancreatic ductal adenocarcinoma cell (PDAC) migration. (17641415)
Mijatovic T.... Decaestecker C.
|42|Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. (18345294)
Clark E.J.... Parks R.W.
|43|Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. (16774944)
Ueda S.... Tsuda H.
|44|HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis. (16685109)
Tsiambas E.... Patsouris E.
|45|The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma. (16618736)
Deng X.... Friedman E.
|46|Monoclonal antibody therapies targeting pancreatic ductal adenocarcinoma. (17430101)
Engelhardt K.... Mahadevan D.
|47|Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. (17079475)
Verma A.... Mehta K.
|48|Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. (11786397)
Rosty C.... Goggins M.
|49|Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. (11943721)
Abraham S.C.... Hruban R.H.
|50|Phenotypical characteristics of undifferentiated carcinoma of the pancreas: a comparison with pancreatic ductal adenocarcinoma and relevance of E-cadherin, alpha catenin and beta catenin expression. (11410776)
Yonemasu H.... Tsuneyoshi M.